ArticleCancer immunology, immunotherapy : CII2021

Combined vaccine-immune-checkpoint inhibition constitutes a promising strategy for treatment of dMMR tumors.

Inken Salewski et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.